MOS
TEVA icon

MGO One Seven’s Teva Pharmaceuticals TEVA Stock Holding History

MGO One Seven’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Sell
5,922
-1,726
-23% -$57.5K ﹤0.01% 1483
2026
Q1 		$230K Sell
7,648
-7,192
-48% -$231K ﹤0.01% 1270
2025
Q4 		$463K Sell
14,840
-1,993
-12% -$49.1K 0.01% 906
2025
Q3 		$340K Buy
16,833
+2,774
+20% +$48.7K 0.01% 975
2025
Q2 		$236K Buy
+14,059
New +$227K 0.01% 1062
2025
Q1 		– Sell
-48,813
Closed -$1.08M – 1187
2024
Q4 		$1.08M Buy
48,813
+33,377
+216% +$607K 0.04% 417
2024
Q3 		$278K Buy
15,436
+478
+3% +$8.37K 0.01% 795
2024
Q2 		$243K Buy
14,958
+3,018
+25% +$46.5K 0.01% 848
2024
Q1 		$168K Buy
+11,940
New +$151K 0.01% 860
2023
Q4 		– Sell
-13,326
Closed -$136K – 953
2023
Q3 		$136K Buy
13,326
+22
+0.2% +$205 0.01% 783
2023
Q2 		$100K Buy
13,304
+39
+0.3% +$316 0.01% 758
2023
Q1 		$117K Sell
13,265
-243
-2% -$2.4K 0.01% 824
2022
Q4 		$123K Sell
13,508
-584
-4% -$5.1K 0.01% 696
2022
Q3 		$113K Buy
14,092
+85
+0.6% +$752 ﹤0.01% 676
2022
Q2 		$105K Sell
14,007
-201
-1% -$1.75K 0.01% 606
2022
Q1 		$133K Buy
+14,208
New +$119K 0.01% 639
2019
Q1 		– Sell
-1,388
Closed -$21K – 1512
2018
Q4 		$21K Buy
+1,388
New +$28.5K 0.01% 909
2018
Q1 		$9K Sell
555
-24
-4% -$469 ﹤0.01% 1138
2017
Q4 		$11K Buy
+579
New +$8.71K 0.01% 1073

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

MGO One Seven's TEVA Position: Q2 2026 in Review

MGO One Seven reduced its Teva Pharmaceuticals (TEVA) stake by 23% in Q2 2026, selling an estimated $57.5K and leaving 5,922 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #1483.

MGO One Seven first reported a position in TEVA in Q4 2017 and has held it in 19 quarters since. The position peaked at $1.08M in Q4 2024. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • MGO One Seven held 5,922 shares of Teva Pharmaceuticals worth $201K as of Q2 2026.
  • MGO One Seven sold 1,726 Teva Pharmaceuticals shares in Q2 2026, an estimated $57.5K.
  • Teva Pharmaceuticals made up ﹤0.01% of MGO One Seven's portfolio in Q2 2026, its #1483 holding.
  • MGO One Seven first reported a position in Teva Pharmaceuticals in Q4 2017 and has held it in 19 quarters since.
  • MGO One Seven's Teva Pharmaceuticals position peaked at $1.08M in Q4 2024.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.